Trial Profile
Treatment of Advanced Head and Neck Cancer With Opioid Growth Factor: Phase II.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 20 May 2013
Price :
$35
*
At a glance
- Drugs Methionine enkephalin (Primary) ; Methionine
- Indications Head and neck cancer
- Focus Therapeutic Use
- 29 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov (NCT00905099).
- 29 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov (NCT00905099).
- 24 Sep 2009 Planned end date changed from Feb 2012 to Dec 2012 as reported by ClinicalTrials.gov (NCT00982696).